Citation

Fretzin M. Cosmetic Dermatology 2004; 17(5): 293-294+297.

Copyright

(Copyright © 2004)

DOI

unavailable

PMID

unavailable

Abstract

Each year, approximately 86,000 patients consult a dermatologist for the erythema, papules, and pustules of rosacea. In addition to identifying and avoiding individual triggers, such as sun and stress, numerous therapies are used to treat the condition. Historically, medications indicated for acne vulgaris were used to treat rosacea. Recently, therapies with specific indications for rosacea have entered the market. These include new sodium sulfacetamide/sulfur products, azelaic acid gel, and topical metronidazole. Individual patient tolerability to these treatments varies. In addition, these medications may take weeks or months to produce visible results. There is a recently introduced product that contains a color-corrective green pigment with sodium sulfacetamide/sulfur in either a water-based gel or an emollient cream vehicle. The green tint may offer patients immediate cosmetic improvement.

Language: en

Keywords

human; violence; suicide; systematic review; aggression; stress; treatment outcome; review; acne vulgaris; behavior disorder; doxycycline; skin abrasion; diarrhea; drug tolerability; erythema; photosensitivity; skin irritation; antibiotic agent; tetracycline; gel; prematurity; avar; azelaic acid; benzoyl peroxide; clenia; clindamycin; emollient agent; erythromycin; fetus malformation; metronidazole; minocycline; papule; permethrin; pustule; retinoic acid; rosacea; rosula; spontaneous abortion; sulfacetamide; sulfur; sun